A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 39317422.
- Also identified by DOI 10.1136/jmg-2024-110202 and PMC identifier 11503160.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
von Hippel-Lindau (VHL) is an autosomal-dominant hereditary tumour susceptibility disease associated with pathogenic germline variants in the <i>VHL</i> tumour suppressor gene. VHL patients are at increased risk of developing multiple benign and malignant tumours. Current CLIA-based genetic tests demonstrate a very high detection rate of germline <i>VHL</i> variants in patients with clinical manifestations of VHL. In this report, we describe a large family with canonical VHL manifestations, for which no germline alteration had been detected by conventional germline testing. We identified a novel 291 kb chromosomal inversion involving chromosome 3p in affected family members. This inversion disrupts the <i>VHL</i> gene between exon 2 and exon 3 and is thereby responsible for the disease observed in this family.
Medical subject headings
- von Hippel-Lindau Disease
- Chromosome Inversion
- Chromosomes, Human, Pair 3
- Germ-Line Mutation
- Pedigree
- Von Hippel-Lindau Tumor Suppressor Protein